BusinessAlder BioPharmaceuticals® Announces First Quarter 2017 Financial and Operating ResultsBy Nasdaq OMXApr 27, 2017, 8:07 PM UTC
BusinessAlder BioPharmaceuticals® Announces First Quarter 2017 Financial and Operating ResultsBy Nasdaq OMXApr 27, 2017, 8:07 PM UTC
BusinessAlder BioPharmaceuticals® Announces First Quarter 2017 Financial and Operating ResultsBy Nasdaq OMXApr 27, 2017, 8:07 PM UTC
BusinessMyriad Genetics and Clovis Oncology Sign Agreement for Use of FDA-Approved BRACAnalysis CDx® Test to Identify Patients with Germline BRCA Mutations for Rubraca® (rucaparib) TreatmentBy Nasdaq OMXApr 27, 2017, 11:05 AM UTC
BusinessProQR Announces Clearance of IND Application to Start Clinical Trial for QR-110 in Leber’s Congenital Amaurosis Type 10 PatientsBy Nasdaq OMXApr 27, 2017, 11:03 AM UTC
BusinessProQR Announces Clearance of IND Application to Start Clinical Trial for QR-110 in Leber’s Congenital Amaurosis Type 10 PatientsBy Nasdaq OMXApr 27, 2017, 11:03 AM UTC
BusinessProQR Announces Clearance of IND Application to Start Clinical Trial for QR-110 in Leber’s Congenital Amaurosis Type 10 PatientsBy Nasdaq OMXApr 27, 2017, 11:03 AM UTC
BusinessProQR Announces Clearance of IND Application to Start Clinical Trial for QR-110 in Leber’s Congenital Amaurosis Type 10 PatientsBy Nasdaq OMXApr 27, 2017, 11:02 AM UTC
